166 related articles for article (PubMed ID: 5650037)
21. Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis.
Smeets ME; Vreugdenhil G; Holdrinet RS
Am J Hematol; 1996 Mar; 51(3):243-4. PubMed ID: 8619408
[No Abstract] [Full Text] [Related]
22. [Clinical and metabolic research on treatment with desferrioxamine B in various hemosiderotic erythrocyte diseases].
Cimino R; Quattrin N
Clin Ter; 1965 Jul; 34(1):3-32. PubMed ID: 5840761
[No Abstract] [Full Text] [Related]
23. [Therapy of hemosiderosis with deferoxamine].
Strohmeyer G; Stremmel W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1669-70. PubMed ID: 6489179
[No Abstract] [Full Text] [Related]
24. [A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
Vadász G
MMW Munch Med Wochenschr; 1974 Nov; 116(47):2077-80. PubMed ID: 4216814
[No Abstract] [Full Text] [Related]
25. [Effect of continuous subcutaneous infusion of deferoxamine in a boy with congenital hypoplastic anemia].
Ishitoya N; Gomibuchi I; Fujisawa K; Akatsuka J
Rinsho Ketsueki; 1988 Sep; 29(9):1408-12. PubMed ID: 3216512
[No Abstract] [Full Text] [Related]
26. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
[TBL] [Abstract][Full Text] [Related]
27. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Kirimlidis S; Philippidis P; Drossos C; Economidis J
Helv Paediatr Acta; 1966 Sep; 21(4):343-50. PubMed ID: 5997620
[No Abstract] [Full Text] [Related]
28. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
Krüger N; Kijewski H; König R; Tillmann W; Schröter W
Dtsch Med Wochenschr; 1984 Nov; 109(44):1682-5. PubMed ID: 6489181
[TBL] [Abstract][Full Text] [Related]
29. [The use of desferrioxamine in iron poisoning and hemosiderosis].
Karlsson B; Lagercrantz R; Brann I; Strandberg O; Reizenstein P
Nord Med; 1965 Oct; 74(40):985-8. PubMed ID: 5836665
[No Abstract] [Full Text] [Related]
30. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
Orsini A; Giraud F; Bernard P; Passeron P
Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127
[No Abstract] [Full Text] [Related]
31. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
[No Abstract] [Full Text] [Related]
32. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
Girot R; Thévenin M; Bouveret JP; Jeannel F; Rymer JC
Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hemodialysis hemosiderosis with desferrioxamine.
Rembold CM; Krumlovsky FA; Roxe DM; Fitzsimmons E; del Greco F
Trans Am Soc Artif Intern Organs; 1982; 28():621-6. PubMed ID: 7164314
[No Abstract] [Full Text] [Related]
34. [Desferrioxamine in patients with hemochromatosis and hemosiderosis].
Maspes V; Tamigaki M; Gomes ZJ; Jamra M
Rev Hosp Clin Fac Med Sao Paulo; 1966; 21(4):181-95. PubMed ID: 5918167
[No Abstract] [Full Text] [Related]
35. [Sideroblastic anemias].
Löhr GW
Verh Dtsch Ges Inn Med; 1978; (84):71-8. PubMed ID: 369209
[No Abstract] [Full Text] [Related]
36. [Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
Muranda M; Velasco M; Giménez E; Ruiz J; Bastías E; Rodriguez J; Etcheverry R; Guzmán C; Regonesi C; Janklevich S
Rev Med Chil; 1965 Apr; 93(4):127-33. PubMed ID: 5832943
[No Abstract] [Full Text] [Related]
37. [Desferal treatment of hemosiderosis in hemoglobinopathies (based on records from Kuveit)].
Khutsishvili GE
Ter Arkh; 1971 Oct; 43(10):98-101. PubMed ID: 4258785
[No Abstract] [Full Text] [Related]
38. Transfusion haemosiderosis inspite of regular use of desferrioxamine: case report.
Mwanda OW; Otieno CF; Abdalla FK
East Afr Med J; 2004 Jun; 81(6):326-8. PubMed ID: 16167682
[TBL] [Abstract][Full Text] [Related]
39. [Erythroblastic aplasia in an adolescent].
Fleury J; Soulier JP; de Menibus CH; Hazard E
Nouv Rev Fr Hematol; 1970; 10(5):583-96. PubMed ID: 4250281
[No Abstract] [Full Text] [Related]
40. [A new iron chelating agent: desferrioxamine B (Desferal). Clinico-pharmacological observations. Cases].
Gallinelli R; Coppini D
Minerva Med; 1965 Nov; 56(92):3980-5. PubMed ID: 5845686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
